Status:
COMPLETED
Improving Pain and Function in Hip Fracture
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Pain
Hip Fractures
Eligibility:
All Genders
60+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare two different methods of treating pain after a hip fracture.
Detailed Description
This project examines the efficacy and effects of 2 regional anesthesia techniques, femoral nerve blocks (FNB) and fascia iliaca blocks (FIB), on the treatment of peri-operative acute hip (femoral nec...
Eligibility Criteria
Inclusion
- All adult patients 60 years of age and over that present to the MSMC ED from 8:00 to 20:00 with a radiographically confirmed hip fracture (femoral neck, intertrochanteric, or peri-capsular) will be screened for study eligibility.
Exclusion
- History of advanced dementia
- Presence of multiple trauma, pathological fractures, bilateral hip fractures, or previous fracture or surgery at the currently fractured site
- Patients transferred from another hospital
- Patients with cirrhosis or liver failure.
- The investigators exclude patients with advanced dementia because the investigators will require patients to self-report their pain intensity.
- The investigators exclude these categories of hip fracture because they represent patients with atypical or often problematic clinical circumstances.
- The investigators exclude patients under age 60 because our focus is on treatment of pain in older adults. Younger adults (less than age 60) typically present with fractures of different cause (severe and multiple trauma), are less sensitive to the side effects and complications of opioid therapy, are less likely to have delayed or prolonged functional recovery, and are less sensitive to the adverse and sometimes permanent effects of prolonged bed rest (i.e., from pain) on function.
- The investigators exclude patients with hepatic dysfunction because the intervention protocol includes administration of acetaminophen which can provoke liver failure in patients with advanced liver disease.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT00749489
Start Date
November 1 2008
End Date
May 1 2014
Last Update
June 25 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel
New York, New York, United States, 10003
2
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
3
Maimonides Medical Center
New York, New York, United States, 11219